CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $129,865 | -13.3% | 11,109 | -0.3% | 0.01% | 0.0% |
Q2 2023 | $149,816 | -18.7% | 11,147 | +0.3% | 0.01% | -25.0% |
Q1 2023 | $184,188 | +43650.1% | 11,109 | -51.0% | 0.01% | -27.3% |
Q4 2022 | $421 | -99.7% | 22,652 | +103.9% | 0.01% | +10.0% |
Q3 2022 | $143,000 | +83.3% | 11,109 | 0.0% | 0.01% | +66.7% |
Q2 2022 | $78,000 | -15.2% | 11,109 | 0.0% | 0.01% | +20.0% |
Q1 2022 | $92,000 | +22.7% | 11,109 | 0.0% | 0.01% | +25.0% |
Q4 2021 | $75,000 | +27.1% | 11,109 | 0.0% | 0.00% | +33.3% |
Q3 2021 | $59,000 | -7.8% | 11,109 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $64,000 | +25.5% | 11,109 | 0.0% | 0.00% | +33.3% |
Q1 2021 | $51,000 | +37.8% | 11,109 | 0.0% | 0.00% | +50.0% |
Q4 2020 | $37,000 | +12.1% | 11,109 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $33,000 | -35.3% | 11,109 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $51,000 | +18.6% | 11,109 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $43,000 | +2.4% | 11,109 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $42,000 | -28.8% | 11,109 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $59,000 | +37.2% | 11,109 | 0.0% | 0.01% | +50.0% |
Q2 2019 | $43,000 | -24.6% | 11,109 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $57,000 | +171.4% | 11,109 | 0.0% | 0.01% | +200.0% |
Q4 2018 | $21,000 | -73.8% | 11,109 | -47.4% | 0.00% | -77.8% |
Q3 2018 | $80,000 | +21.2% | 21,109 | 0.0% | 0.01% | +12.5% |
Q2 2018 | $66,000 | +32.0% | 21,109 | 0.0% | 0.01% | +33.3% |
Q1 2018 | $50,000 | -39.8% | 21,109 | 0.0% | 0.01% | -40.0% |
Q4 2017 | $83,000 | +56.6% | 21,109 | 0.0% | 0.01% | +25.0% |
Q3 2017 | $53,000 | -8.6% | 21,109 | 0.0% | 0.01% | -11.1% |
Q2 2017 | $58,000 | +34.9% | 21,109 | -4.5% | 0.01% | +28.6% |
Q1 2017 | $43,000 | +95.5% | 22,109 | +4.7% | 0.01% | +75.0% |
Q4 2016 | $22,000 | -4.3% | 21,109 | 0.0% | 0.00% | -20.0% |
Q3 2016 | $23,000 | +53.3% | 21,109 | 0.0% | 0.01% | +66.7% |
Q2 2016 | $15,000 | -40.0% | 21,109 | 0.0% | 0.00% | -50.0% |
Q1 2016 | $25,000 | -7.4% | 21,109 | +90.0% | 0.01% | -14.3% |
Q4 2015 | $27,000 | -18.2% | 11,109 | 0.0% | 0.01% | -36.4% |
Q3 2015 | $33,000 | -28.3% | 11,109 | 0.0% | 0.01% | -31.2% |
Q2 2015 | $46,000 | – | 11,109 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |